KALA BIO Inc KALA

Healthcare Biotechnology

KALA BIO, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. The Company’s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. The Company’s product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived bio factors, such as growth factors, protease inhibitors, matrix proteins and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its KPI-012 is used for the treatment of persistent corneal epithelial defect (PCED), a rare disease of impaired corneal healing. The Company is also engaged in the development of KPI-012 for the treatment of Limbal Stem Cell Deficiency and other rare corneal diseases.

NDAQ:KALA - Post by User

KALA BIO Inc

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Dec 29, 2022 4:10pm

107 Views

Post# 35195951

KALA..... Can't halt progress ; )

Scalped the cr*p out of this today.... LoL....No skiing for me today.... made a chit ton of dough today.
Still in my robe....no breakfast

My scalps today were ..... ATNF FWBI HOTH KALA NUWE NVIV PALI

Still counting the $'s

Cheers!!!!!

<< Previous

Bullboard Posts

Next >>

Nine Mile Metals completes acquisition of 3 properties